Drug Interaction Knowledge Base Ontology - Drug - Classes | NCBO BioPortal

Drug Interaction Knowledge Base Ontology

Last uploaded: May 19, 2015

Id	http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Drug http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Drug
Preferred Name	Drug
Definitions	"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and /or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life. (NCI04)" Maps to: NCI code: C1908, Instances of this class are also sub-types of NDF-RT "active ingredients" code: C178
Type	http://www.w3.org/2002/07/owl#Class

prefLabel	Drug
comment	"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and /or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life. (NCI04)" Maps to: NCI code: C1908, Instances of this class are also sub-types of NDF-RT "active ingredients" code: C178
type	http://www.w3.org/2002/07/owl#Class
subClassOf	http://www.w3.org/2002/07/owl#Thing
prefixIRI	DIKB_evidence_ontology:Drug
disjointWith	http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#in_vitro_Protein_Source http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Pharmacokinetic_Process http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Journal_Peer_reviewed http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Treatment_Assignment http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Observation_based_DI_Report_Assessment_tool http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Drug_Drug_Interaction http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Drug_Interaction http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Public_Reporting_Database http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#EV_PK_DDI_NR http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Metabolism http://www.biopax.org/release/biopax-level3.owl#UtilityClass http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Drug_Manufacturer http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Evidence_Type http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Pharmacodynamic_Effect_Consequences http://purl.org/net/drug-interaction-knowledge-base/DIKB_evidence_ontology.owl#Pharmacokinetic_Effect_Consequences See more See less

Subscribe to notes emails

Delete	Subject	Author	Type	Created
No notes to display